1,576
Views
32
CrossRef citations to date
0
Altmetric
Research Article

pH-and thermo-sensitive pluronic/poly(acrylic acid) in situ hydrogels for sustained release of an anticancer drug

, &
Pages 54-66 | Received 12 May 2012, Accepted 27 Aug 2012, Published online: 26 Sep 2012

References

  • Ahn JS, Choi HK, Cho CS. (2001). A novel mucoadhesive polymer prepared by template polymerization of acrylic acid in the presence of chitosan. Biomaterials, 22, 923–928.
  • Aisner J. (2007). Overview of the changing paradigm in cancer treatment: Oral chemotherapy. Am J Health Syst Pharm, 64, S4–S7.
  • Alakhova DY, Rapoport NY, Batrakova EV, Timoshin AA, Li S, Nicholls D, Alakhov VY, Kabanov AV. (2010). Differential metabolic responses to pluronic in MDR and non-MDR cells: A novel pathway for chemosensitization of drug resistant cancers. J Control Release, 142, 89–100.
  • Attwood D, Zhou Z, Booth C. (2007). Poly(ethylene oxide) based copolymers: Solubilisation capacity and gelation. Expert Opin Drug Deliv, 4, 533–546.
  • Barthe L, Woodley J, Houin G. (1999). Gastrointestinal absorption of drugs: Methods and studies. Fundam Clin Pharmacol, 13, 154–168.
  • Batrakova EV, Li S, Brynskikh AM, Sharma AK, Li Y, Boska M, Gong N, Mosley RL, Alakhov VY, Gendelman HE, Kabanov AV. (2010). Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers. J Control Release, 143, 290–301.
  • Blower P, de Wit R, Goodin S, Aapro M. (2005). Drug-drug interactions in oncology: Why are they important and can they be minimized? Crit Rev Oncol Hematol, 55, 117–142.
  • Bromberg L. (2008). Polymeric micelles in oral chemotherapy. J Control Release, 128, 99–112.
  • Falkson G, Vorobiof DA. (1984). Epirubicin in colorectal cancer. In: Bonadonna G, ed. Advances in anthracycline chemotherapy: Epirubicin. Masson: Italia Editori, 105–109.
  • Haley B, Frenkel E. (2008). Nanoparticles for drug delivery in cancer treatment. Urol Oncol, 26, 57–64.
  • He C, Kim SW, Lee DS. (2008). In situ gelling stimuli-sensitive block copolymer hydrogels for drug delivery. J Control Release, 127, 189–207.
  • Huang Y, Yu H, Xiao C. (2007). pH-sensitive cationic guargum/poly (acrylic acid) polyelectrolyte hydrogels: Swelling and in vitro drug release. Carbohydr Polym, 69, 774–783.
  • Kao HJ, Lin HR, Lo YL, Yu SP. (2006). Characterization of pilocarpine-loaded chitosan/Carbopol nanoparticles. J Pharm Pharmacol, 58, 179–186.
  • Kim IY, Yoo MK, Kim BC, Kim SK, Lee HC, Cho CS. (2006). Preparation of semi-interpenetrating polymer networks composed of chitosan and poloxamer. Int J Biol Macromol, 38, 51–58.
  • Kim KS, Park SJ. (2010). Effect of porous silica on sustained release behaviors of pH sensitive pluronic F127/poly(acrylic acid) hydrogels containing tulobuterol. Colloids Surf B Biointerfaces, 80, 240–246.
  • Lin HR, Sung KC, Vong WJ. (2004). In situ gelling of alginate/pluronic solutions for ophthalmic delivery of pilocarpine. Biomacromolecules, 5, 2358–2365.
  • Lin HR, Tseng CC, Lin YJ, Ling MH. (2012). A novel in-situ-gelling liquid suppository for site-targeting delivery of anti-colorectal cancer drugs. J Biomater Sci Polym Ed, 23, 807–822.
  • Lo YL, Ho CT, Tsai FL. (2008). Inhibit multidrug resistance and induce apoptosis by using glycocholic acid and epirubicin. Eur J Pharm Sci, 35, 52–67.
  • O’Neill VJ, Twelves CJ. (2002). Oral cancer treatment: Developments in chemotherapy and beyond. Br J Cancer, 87, 933–937.
  • Park H, Robinson JR. (1987). Mechanisms of mucoadhesion of poly(acrylic acid) hydrogels. Pharm Res, 4, 457–464.
  • Park TH, Kim ST, Park JS, Choi HG, Kim HT, Kim CK. (2010). Effect of zinc oxide on the rheological and mucoadhesive properties of poloxamer 407-based mucoadhesive thermosensitive gel. Drug Dev Ind Pharm, 36, 1436–1443.
  • Plosker GL, Faulds D. (1993). Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy. Drugs, 45, 788–856.
  • Ranjha NM, Ayub G, Naseem S, Ansari MT. (2010). Preparation and characterization of hybrid pH-sensitive hydrogels of chitosan-co-acrylic acid for controlled release of verapamil. J Mater Sci Mater Med, 21, 2805–2816.
  • Ruel-Gariépy E, Leroux JC. (2004). In situ-forming hydrogels–review of temperature-sensitive systems. Eur J Pharm Biopharm, 58, 409–426.
  • Tian JL, Zhao YZ, Jin Z, Lu CT, Tang QQ, Xiang Q, Sun CZ, Zhang L, Xu YY, Gao HS, Zhou ZC, Li XK, Zhang Y. (2010). Synthesis and characterization of Poloxamer 188-grafted heparin copolymer. Drug Dev Ind Pharm, 36, 832–838.
  • Xuan JJ, Balakrishnan P, Oh DH, Yeo WH, Park SM, Yong CS, Choi HG. (2010). Rheological characterization and in vivo evaluation of thermosensitive poloxamer-based hydrogel for intramuscular injection of piroxicam. Int J Pharm, 395, 317–323.
  • Yong CS, Oh YK, Jung SH, Rhee JD, Kim HD, Kim CK, Choi HG. (2004). Preparation of ibuprofen-loaded liquid suppository using eutectic mixture system with menthol. Eur J Pharm Sci, 23, 347–353.
  • Yong CS, Oh YK, Kim YI, Kim JO, Yoo BK, Rhee JD, Lee KC, Kim DD, Park YJ, Kim CK, Choi HG. (2005). Physicochemical characterization and in vivo evaluation of poloxamer-based solid suppository containing diclofenac sodium in rats. Int J Pharm, 301, 54–61.
  • Yoo MK, Kweon HY, Lee KG, Lee HC, Cho CS. (2004). Preparation of semi-interpenetrating polymer networks composed of silk fibroin and poloxamer macromer. Int J Biol Macromol, 34, 263–270.
  • Zhang XX, Pan WS, Gan L, Zhu CL, Gan Y. (2008). Effects of breast cancer resistance protein inhibitors and pharmaceutical excipients on decreasing gastrointestinal toxicity of camptothecin analogs. Acta Pharmacol Sin, 29, 1391–1398.
  • Zhang W, Shi Y, Chen Y, Hao J, Sha X, Fang X. (2011a). The potential of Pluronic polymeric micelles encapsulated with paclitaxel for the treatment of melanoma using subcutaneous and pulmonary metastatic mice models. Biomaterials, 32, 5934–5944.
  • Zhang W, Shi Y, Chen Y, Ye J, Sha X, Fang X. (2011b). Multifunctional Pluronic P123/F127 mixed polymeric micelles loaded with paclitaxel for the treatment of multidrug resistant tumors. Biomaterials, 32, 2894–2906.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.